Watson Pharmaceuticals' generic version of the Plan B morning-after contraceptive pill received FDA approval for women 18 and older. The company plans to launch the nonprescription drug Aug. 24, when Duramed Pharmaceuticals' market exclusivity for Plan B expires. The generic version will be available for women 17 and younger by prescription only.

Related Summaries